CM
ALXN

Caption Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Caption Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,200
Closed -$2.78M – 1685
2021
Q1 		$2.78M Sell
18,200
-67,300
-79% -$10.4M 0.06% 420
2020
Q4 		$13.4M Buy
85,500
+15,500
+22% +$1.99M 0.3% 81
2020
Q3 		$8.01M Buy
70,000
+20,200
+41% +$2.18M 0.19% 127
2020
Q2 		$5.59M Sell
49,800
-37,100
-43% -$3.94M 0.19% 146
2020
Q1 		$7.8M Buy
86,900
+60,300
+227% +$5.92M 0.44% 41
2019
Q4 		$2.88M Sell
26,600
-7,400
-22% -$791K 0.1% 286
2019
Q3 		$3.33M Buy
34,000
+18,000
+113% +$2.03M 0.17% 157
2019
Q2 		$2.1M Buy
+16,000
New +$2.06M 0.11% 235

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Caption Management's ALXN Position: Q2 2021 in Review

Caption Management sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 18,200 shares — an estimated $2.78M sold.

Caption Management first reported a position in ALXN in Q2 2019 and held it in 8 quarters. The position peaked at $13.4M in Q4 2020. 708 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Caption Management reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Caption Management sold 18,200 Alexion Pharmaceuticals shares in Q2 2021, an estimated $2.78M.
  • Caption Management first reported a position in Alexion Pharmaceuticals in Q2 2019 and held it in 8 quarters.
  • Caption Management's Alexion Pharmaceuticals position peaked at $13.4M in Q4 2020.
  • 708 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Caption Management's 13F filing for Q2 2021, filed 16 Aug 2021.